Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 April 2024 | Story Andre Damons | Photo Charl Devenish
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), received the first clinical PhD in nuclear medicine completed at the UFS at the April graduation ceremonies.

Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine, Faculty of Health Sciences, at the University of the Free State (UFS), graduated with the first clinical PhD in nuclear medicine completed at the UFS.

He graduated on Thursday (18 April 2024) at the university’s autumn graduation ceremonies when the Faculty of Health Sciences conferred degrees on its graduation class of 2024.

Dr Evbuomwan, the man behind his department using Lutetium 177 PSMA (Lu-177 PSMA) therapy and now Actinium 225 PSMA therapy to treatment metastatic castrate resistant prostate cancer (MCRPC) – an advanced stage prostate cancer, said his PhD is about using a special radiopharmaceutical called Technetium 99m ECDG to detect active disease in the joints of patients with rheumatoid arthritis (RA).

More opportunities for similar degrees

This research has won him the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa during last year’s SNMMI 2023 Annual Meeting in the US.

“I am very grateful, and at the same time, proud about this achievement (his PhD). This qualification will definitely give more opportunities for further similar degrees at the department. So yes, I feel very happy and fulfilled.

“Rheumatoid arthritis is a debilitating disease with associated morbidity that can lead to serious joint deformity and destruction. The need for an investigation with a very high diagnostic accuracy in detecting active disease is needed, especially in the detection of subclinical disease. Few prior studies in the literature had shown promising results with Tc 99m ECDG imaging in this regard. So, we decided to conduct a proper prospective study to test this hypothesis,” says Dr Evbuomwan.

This research, he explains, was also aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. This aspect of the study concluded that this particular radiopharmaceutical (Tc – 99m ECDG) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints) and is capable of offering prognostic information in patients with rheumatoid arthritis.

This was the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says.

Researching theranostics in the future

According to him, he had a smooth journey to completing his PhD – something he contributes to support from the fantastic team of three supervisors, the assistant who prepared the radiopharmaceutical, the rheumatology department, the radiographers and nurses at the Department of Nuclear Medicine, and most importantly, his wife and two daughters.

His passion for research, growth and the practice of nuclear medicine were his major motivators on this journey.

Dr Evbuomwan is currently looking at the possibility of starting research on theranostics. The only stumbling block for now, he says, is that the department still does not have a PET/CT camera, as this is very vital in today’s nuclear medicine practice. However, together with the Free State Department of Health, they are working hard to secure one.

“I now want to focus on nuclear medicine therapy and its promotion. This includes both imaging and treatment (theranostics) of certain cancers, most especially prostate cancer, neuroendocrine neoplasms, thyroid cancers and the neuroectodermal tumours. I also want to focus on being involved with the training of more registrars at the department of nuclear medicine and increasing the awareness of nuclear medicine amongst colleagues in the Free State,” says Dr Evbuomwan about his future plans. 

News Archive

A call for next generation of professors: Apply for the Vice-Chancellor’s Prestige Scholars’ Programme
2014-12-19

 

Examples of the rector's prestige scholars' international footprint: Dr Olihile Sebolai, Fulbright scholar (left) returned to the UFS after six months at the University of Birmingham and three at the University of Missouri. Dr Cilliers van den Berg (right) visited Cornell University on a ten-month sabbatical.

The Vice-Chancellor’s Prestige Scholars’ Programme (PSP) seeks to identify, develop and promote the next cohort of the most promising and talented UFS academic members of staff who obtained a doctoral degree within the last five years or will graduate by June 2015.

Scholars identified benefit from an intensive programme of academic and professional support that includes an advanced residential programme, exposure to leading scholars, concentrated reading and writing programmes, high-level seminar participation and presentation, nuanced publication schedules and personal mentoring and advice, including participation in the annual PSP mock NRF rating and the development of a postdoctoral intellectual project for funding submission (Thuthuka, and similar).

Past prestige scholars have become Fulbright scholars, received funding from among others the Association of Commonwealth Universities, the Japan Society for the Promotion of Science, Erasmus Mundus, NRF Blue Skies, Thuthuka, etc. They have spent time at universities in Canada, the USA, United Kingdom, Europe and Japan.

This year the selection process will be anticipated by pre-selection. Final selection to the programme will take place in September 2015. The selection is highly competitive, and aimed at those young scholars with the potential to obtain upper-level NRF ratings (Y1 and P).

Criteria for selection:

Recently obtained a PhD degree. 
Evidence of an active publication record. 
Early recognition of scholarly work, e.g. successful funding/grant applications and academic awards. 
The early development of a post-doctoral intellectual project that shows evidence of scholarly “potential” (defined by the NRF Y-category). 
Indication of the young scholar’s understanding of what their envisaged postdoctoral endeavours will contribute to the body of disciplinary knowledge. 
Full participation in the pre-selection residential programme and activities is a requirement for selection.

Call for interest: 2015 (PDF)

Requests for further information can be directed to Prof Jackie du Toit at dutoitjs@ufs.ac.za.

Applications close on 16 February 2015.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept